ISSN:
1432-1041
Keywords:
Doxazosin
;
Hypertension
;
Diabetes mellitus
;
non-insulin dependent diabetes mellitus
;
insulin sensitivity
;
serum lipids
;
adverse drug effects
Source:
Springer Online Journal Archives 1860-2000
Topics:
Chemistry and Pharmacology
,
Medicine
Notes:
Summary The effect of doxazosin, an a,-adrenoceptor blocking drug, on blood pressure, sensitivity to insulin and serum lipids has been evaluated in 14 hypertensive, non-insulin dependent diabetic patients. The dose was titrated individually upwards from 1 mg until the diastolic blood pressure was below 90 mm Hg, side-effects precluded further dosage increase or the maximum daily dose of 16 mg was achieved. After 12 weeks of treatment (mean doxazosin dose 5.6 ± 5.1 mg daily), the supine and standing diastolic blood pressure of the patients had declined by about 7 mmHg, whereas their systolic blood pressure and heart rate were not significantly changed. The metabolic clearance rate of glucose increased from 2.35 to 3.37 ml - min−1 - kg−1 during treatment, suggesting improved sensitivity to insulin. Fasting plasma glucose was 11.9 mmol·1−1 before and 10.9 mmol·l−1 after doxazosin therapy (NS). Serum electrolytes and lipids did not change significantly but serum uric acid decreased from 305 to 281 μmol · 1−1 Doxazosin may be a useful alternative for the treatment of hypertension in NIDDM patients.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF02220610
Permalink
